1. Home
  2. AZN

as 11-14-2025 12:18pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Founded: 1992 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 255.5B IPO Year: 1993
Target Price: N/A AVG Volume (30 days): 4.4M
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
1.73%
Dividend Payout Frequency: Semi-Annual
EPS: 6.02 EPS Growth: 45.02
52 Week Low/High: $61.24 - $89.43 Next Earning Date: 11-06-2025
Revenue: $58,127,000,000 Revenue Growth: 13.52%
Revenue Growth (this year): 10.78% Revenue Growth (next year): 6.03%

AZN Daily Stock ML Predictions

Share on Social Networks: